Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rank in Stocks
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Share Price
$8.03
Market Cap
$6.31B
Change (1 day)
1.07%
Change (1 year)
-8.04%
Country
CN
Trade Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Category
Healthcare
P/S ratio for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
P/S ratio as of October 2026 TTM: 8.75
According to Shenzhen New Industries Biomedical Engineering Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.75. At the end of 2024 the company had a P/S ratio of 12.27.
P/S ratio history for Shenzhen New Industries Biomedical Engineering Co., Ltd. from 2012 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 8.75 | -9.40% |
| 2025 | 9.66 | -21.32% |
| 2024 | 12.27 | -21.47% |
| 2023 | 15.63 | 20.88% |
| 2022 | 12.93 | -4.70% |
| 2021 | 13.57 | -45.22% |
| 2020 | 24.77 | 123.84% |
| 2019 | 11.06 | -8.57% |
| 2018 | 12.10 | -17.57% |
| 2017 | 14.68 | -19.11% |
| 2016 | 18.15 | -19.42% |
| 2015 | 22.52 | -24.61% |
| 2014 | 29.87 | -30.65% |
| 2013 | 43.08 | -31.74% |
| 2012 | 63.12 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 3.74 | -57.32% |
US
|
|
| 3.23 | -63.08% |
IE
|
|
| 4.58 | -47.71% |
US
|
|
| 3.07 | -64.89% |
US
|
|
| 2.02 | -76.95% |
DE
|
